Skip to main content

Table 1 Baseline patient characteristics after PSM

From: Effect of continuous infusion of dexmedetomidine on blood loss in orthognathic surgery: a retrospective study

Variable

Dexmedetomidine group

Control group

P Value

Number

540

540

/

Age (y), mean ± SD

23.66 ± 4.37

23.55 ± 4.27

0.694

Height (cm), mean ± SD

166.30 ± 8.52

166.49 ± 8.31

0.699

Weight (kg), mean ± SD

59.20 ± 11.09

59.20 ± 11.58

0.993

Gender (M/F)

188/352

190/350

0.899

Preoperative haemoglobin (g/L), mean ± SD

128.92 ± 14.67

128.82 ± 14.91

0.915

PLT (× 109/L), mean ± SD

240.25 ± 47.93

241.29 ± 54.16

0.739

PT (s), mean ± SD

11.39 ± 0.93

11.37 ± 0.81

0.660

APTT (s), mean ± SD

28.36 ± 2.38

28.17 ± 2.39

0.174

ANH(mL), mean ± SD

353.51 ± 128.23

352.22 ± 139.49

0.874

Patients with ANH/patients without ANH

496/44

490/50

0.517

Preoperative MAP (mmHg)

86.47 ± 8.40

86.68 ± 8.55

0.681

Preoperative HR (bpm)

80.80 ± 9.41

81.03 ± 10.04

0.711

BIS

17.70 ± 4.99

17.64 ± 4.95

0.854

Crystalloid fluids (mL)

2780.46 ± 520.06

2804.81 ± 555.07

0.457

colloid fluids (mL)

388.89 ± 350.81

387.96 ± 372.95

0.966

  1. PSM Propensity Score Matching, SD standard deviation, BMI body mass index, PLT platelet, PT prothrombin time, APTT activated partial thromboplastin time, ANH acute normovolemic hemodilution, MAP mean arterial pressure, bpm beat per minute, BIS bispectral index